Literature DB >> 20552176

Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Gloria Cereza1, Antonia Agustí, Consuelo Pedrós, Antonio Vallano, Cristina Aguilera, Immaculada Danés, Xavier Vidal, Josep Maria Arnau.   

Abstract

OBJECTIVES: A continuous intervention based on healthcare management agreements was associated in our hospital with an increase in the absolute number of spontaneous reporting of adverse drug reactions (ADRs), and also with an increase in the number of reports of serious or unexpected ADRs and ADRs associated with new drugs. The objective was to analyse the effect of this intervention on the features of ADRs spontaneously reported in a hospital, the drugs involved and the number of signals identified.
METHODS: A longitudinal study with two periods, the 1st period without intervention from 1998 to 2002 and the 2nd period with intervention from 2003 to 2005, was carried out in a tertiary teaching hospital. Changes between the two periods with regard to the following variables were analysed: the patients' characteristics, such as gender and age; the reported ADRs, and the medical assistance required; the suspected drugs involved in the ADRs; the main signals identified.
RESULTS: Gender and age distribution of patients described in the spontaneous reports were no different in the two periods. During the second period, spontaneously reported cases requiring hospital admission and those occurring in hospital increased (236 from 2 in the first period and 277 from 99 in the first period respectively) and cases from outpatient hospital consultations began to be reported (13.9% of reports). The spontaneous reporting on all kinds of ADRs and drugs increased during the second period. Cutaneous reactions were the most frequently spontaneously reported ADRs in both periods followed by cardiovascular and neurological reactions in the first period, and haematological and gastrointestinal reactions in the second one. However, during the second period the higher increase was for endocrinological, urinary and hepatic reactions. Systemic antibiotics, anti-thrombotics and cardiac therapy drugs were the most common therapeutic subgroups reported to be suspected drugs in both periods, but in the second period the proportion of immunostimulants, beta blocking agents, immunosuppressants and psychoanaleptics increased. No signals were recognised during the first period; however, two signals and one additional safety concern were identified during the second.
CONCLUSION: An intervention based on healthcare management agreements, was associated with an important increase in spontaneous reporting of ADRs by hospital physicians and also with a change in terms of the type of ADRs identified affecting different organs or systems, and the therapeutic groups of drugs involved. Future studies should analyse the effect of different types of intervention on the spontaneous reporting of ADRs in hospitals.

Entities:  

Mesh:

Year:  2010        PMID: 20552176     DOI: 10.1007/s00228-010-0856-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

Review 1.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

3.  Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.

Authors:  Stephanie Lugardon; Karine Desboeuf; Pierre Fernet; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

4.  Adverse drug reactions--no farewell to harms.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

5.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

6.  Adverse drug reactions: finding the needle in the haystack.

Authors:  I R Edwards
Journal:  BMJ       Date:  1997-08-30

7.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

8.  Under-reporting of adverse drug reactions in general practice.

Authors:  Y Moride; F Haramburu; A A Requejo; B Bégaud
Journal:  Br J Clin Pharmacol       Date:  1997-02       Impact factor: 4.335

9.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

10.  Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports.

Authors:  A R Cox; C Anton; C H Goh; M Easter; N J Langford; R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

View more
  6 in total

Review 1.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

2.  Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana.

Authors:  Anthony Amalba; Amos Adapalala Bugri
Journal:  Pan Afr Med J       Date:  2021-02-19

3.  Adverse Drug Reactions and quality deviations monitored by spontaneous reports.

Authors:  Marília Berlofa Visacri; Cinthia Madeira de Souza; Catarina Miyako Shibata Sato; Silvia Granja; Mécia de Marialva; Priscila Gava Mazzola; Patricia Moriel
Journal:  Saudi Pharm J       Date:  2014-07-02       Impact factor: 4.330

4.  Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China.

Authors:  Huan Fang; Xiaowen Lin; Jun Zhang; Zhen Hong; Kenji Sugiyama; Takao Nozaki; Tetsuro Sameshima; Susumu Kobayashi; Hiroki Namba; Tetsuya Asakawa
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-26       Impact factor: 2.483

5.  Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.

Authors:  Tahmine Salehi; Naiemeh Seyedfatemi; Mohammad Saeed Mirzaee; Maryam Maleki; Abbas Mardani
Journal:  Biomed Res Int       Date:  2021-04-09       Impact factor: 3.411

6.  Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?

Authors:  Pramod Kumar Sharma; Surjit Singh; Puneet Dhamija
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.